Results 31 to 40 of about 23,468 (210)

Dispersive micro solid phase extraction based on surface magnetic molecular imprinted polymer and deep eutectic solvent with optimization by central composite design for determination of dipyridamole in pharmaceutical and biological samples [PDF]

شیمی کاربردی روز, 2021
In this work, a simple and inexpensive dispersive micro solid-phase extraction method using magnetic molecular imprinted polymer nanocomposite and deep eutectic solvent and optimization by central compound design method was developed for selective ...
Roya Mirzajani, Sara Karami
doaj   +1 more source

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

New England Journal of Medicine, 2008
BACKGROUND Recurrent stroke is a frequent, disabling event after ischemic stroke. This study compared the efficacy and safety of two antiplatelet regimens — aspirin plus extendedrelease dipyridamole (ASA–ERDP) versus clopidogrel.
R. Sacco, H. Diener, S. Yusuf, Daniel Cotton, S. Ôunpuu, W. A. Lawton, Y. Palesch, Renee' H. Martin, G. Albers, P. Bath, N. Bornstein, B. Chan, Sien‐Tsong Chen, L. Cunha, B. Dahlöf, J. De Keyser, G. Donnan, C. Estol, P. Gorelick, Vivian Gu, K. Hermansson, Lutz Hilbrich, M. Kaste, Chuanzhen Lu, T. Machnig, P. Pais, R. Roberts, V. Skvortsova, P. Teal, D. Toni, Cam P. VanderMaelen, T. Voigt, M. Weber, B. Yoon   +33 more
semanticscholar   +1 more source

Bone Regeneration in Critical Bone Defects Using Three-Dimensionally Printed β-Tricalcium Phosphate/Hydroxyapatite Scaffolds Is Enhanced by Coating Scaffolds with Either Dipyridamole or BMP-2

Journal of Biomedical Materials Research. Part B - Applied biomaterials, 2015
Bone defects resulting from trauma or infection need timely and effective treatments to restore damaged bone. Using specialized three-dimensional (3-D) printing technology we have created custom 3-D scaffolds of hydroxyapatite (HA)/Beta-Tri-Calcium ...
S. Ishack, A. Mediero, T. Wilder, J. Ricci, B. Cronstein   +4 more
semanticscholar   +1 more source

Effects of Dpyridamole on Histopathology of Salivary Glands in Rabbits [PDF]

Al-Rafidain Dental Journal
Aims: Dipyridamole is a well-known coronary vasodilator. It is an adenosine reuptake inhibitor leading to increased blood levels of adenosine. So, this study aims to investigate the effects of systemic administration of dipyridamole on the salivary gland
Abdulsattar S. Mahmood, Faehaa Azher Al-Mashhadane, Asmaa Y. Thanoon Alnuaimy   +2 more
doaj   +1 more source

Case Series about the Changed Antiplatelet Protocol for Carotid Endarterectomy in a Teaching Hospital: More Patients with Complications?

The Surgery Journal, 2018
Introduction In the Netherlands, clopidogrel monotherapy increasingly replaces acetylsalicylic acid and extended release dipyridamole as the first-choice antiplatelet therapy after ischemic stroke.
Martijn S. Marsman, Denise M.D. Özdemir- van Brunschot, Abdelkarime Kh Jahrome, Nic J.G.M. Veeger, Wouter J. Schuiling, Frank G. van Rooij, Giel G. Koning   +6 more
doaj   +1 more source

Primary cardiovascular preventive effect of thiazolidinedione in adults with type 2 diabetes: A nationwide cohort study in Korea

Journal of Diabetes Investigation, EarlyView.
Among Korean adults with type 2 diabetes and no prior cardiovascular disease, thiazolidinedione use was associated with a lower risk of the primary composite outcome of stroke, myocardial infarction, hospitalization for heart failure, and all‐cause mortality compared to dipeptidyl peptidase‐4 inhibitor use. ABSTRACT Background Thiazolidinediones (TZDs)
Yun Young Choi, Jimin Jeon, Minyoul Baik, Joonsang Yoo, Jinkwon Kim   +4 more
wiley   +1 more source

Bioresorbable Scaffolds for Coronary Arteries: Where Do We Stand Today?

VIEW Medicine, Volume 1, Issue 1, August 2026.
Bioresorbable coronary scaffolds are moving from thick strut pitfalls to thinner, stronger, healing‐oriented designs. Integrating advances in materials, guided implantation with preparation, size, and postdilation steps, and resorption aligned to healing, we synthesize clinical evidence and chart a roadmap toward intelligent, transient platforms ...
Junya Matsuda, Tatsuya Watanabe, Satoshi Yuhara, John M. Kelly, Hirotsugu Kurobe, Toshiharu Shinoka   +5 more
wiley   +1 more source

Management tactics in patients with chronic cerebral ischemia during COVID-19 pandemic

Неврология, нейропсихиатрия, психосоматика, 2021
The article describes the current state of evidence of hypertension and diabetes mellitus roles in the pathophysiology of chronic cerebral ischemia (CCI).
A. A. Kulesh
doaj   +1 more source

Dual Action of Dipyridamole in Experimental Rheumatoid Arthritis: Suppression of Joint Inflammation and Upregulation of Muscle Anabolism via Adenosine and AMPK Pathways

Arthritis &Rheumatology, Volume 78, Issue 7, Page 1535-1553, July 2026.
Objective Rheumatoid sarcopenia, characterized by the progressive loss of skeletal muscle mass and function, is a frequent comorbidity in rheumatoid arthritis (RA), linked to prolonged, severe systemic inflammation. Purinergic signaling (adenosine, AMP, and ATP) plays a crucial role in inflammation, myogenesis, and muscle hypertrophy.
Miguel Marco‐Bonilla, Maria Fresnadillo, Irene Sanchez‐Platero, Macarena de la Riva‐Bueno, Fernando Huete‐Toral, Gonzalo Carracedo, Carmen Conde, Yolanda Benitez, Pablo Minguez, Sandra Carolina Cifuentes, Joaquin Rams, Gabriel Herrero‐Beaumont, Raquel Largo, Aránzazu Mediero   +13 more
wiley   +1 more source

Cardiorenal Outcomes of Dapagliflozin vs. Empagliflozin in Advanced Chronic Kidney Disease and Diabetes

Clinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 168-177, July 2026.
Target trial emulation of a multi‐institutional electronic health record network showed comparable cardiorenal effectiveness and safety of dapagliflozin versus empagliflozin in adults with type 2 diabetes and advanced‐stage chronic kidney disease.
Shih‐Hsuan Lin, Jia‐Jin Chen, Ching‐Chung Hsiao, Yu‐Wei Fang, Meng‐Ting Chen, Ming‐Hsien Tsai, Huang‐Yu Yang   +6 more
wiley   +1 more source